Literature DB >> 18854316

Selective regulation of heme oxygenase-1 expression and function by insulin through IRS1/phosphoinositide 3-kinase/Akt-2 pathway.

Pedro Geraldes1, Kunimasa Yagi, Yuzuru Ohshiro, Zhiheng He, Yasuhiro Maeno, Junko Yamamoto-Hiraoka, Christian Rask-Madsen, Su Wol Chung, Mark A Perrella, George L King.   

Abstract

Heme oxygenase 1 (HO-1) is a representative mediator of antioxidants and cytoprotectants against various stress stimuli including oxidants in vascular cells. Intensive insulin treatment can delay the onset and progression of diabetic retinopathy and other vascularopathies, yet little is known about insulin regulation of anti-apoptotic and antioxidant molecules such as HO-1 in vascular cells. Intravitreous injection or in vitro addition of insulin increased HO-1 protein expression in rat retina and in cultured bovine retinal pericytes, retinal endothelial cells, and retinal pigment epithelial cells. In bovine retinal pericytes, insulin induced mRNA and protein expression of HO-1 in a time- and concentration-dependent manner. Using HO-1 promoter analysis, the luciferase reporter assay showed that induction of HO-1 expression by insulin is mediated by additional response elements in the ho-1 promoter gene, which was not responsive to antioxidants. Insulin-induced HO-1 mRNA expression through activation of PI3-kinase/Akt pathway without affecting ERK and p38 MAPK. Overexpression of an adenoviral vector of native IRS1, IRS2, and Akt dominant negative or small interfering RNA transfection of Akt1 and Akt2 targeted gene demonstrated that insulin regulated HO-1 expression via IRS1 and Akt2 pathway, selectively. Further, insulin treatment prevented H(2)O(2)-induced NF-kappaB and caspase-8 activation and apoptosis via the IRS1/PI3K/Akt2/HO-1 pathway in the pericytes. In conclusion, we suggest that the anti-apoptotic properties of insulin are mediated partly by increasing HO-1 expression at transcriptional level via IRS1/PI3K/Akt2 activation, a potential explanation for how insulin is retarding the progression of microvascular complications induced by diabetes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18854316      PMCID: PMC2590690          DOI: 10.1074/jbc.M807036200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  54 in total

Review 1.  The natural history and epidemiology of diabetic nephropathy. Implications for prevention and control.

Authors:  J V Selby; S C FitzSimmons; J M Newman; P P Katz; S Sepe; J Showstack
Journal:  JAMA       Date:  1990-04-11       Impact factor: 56.272

Review 2.  Regulation of heme oxygenase gene expression.

Authors:  S Shibahara
Journal:  Semin Hematol       Date:  1988-10       Impact factor: 3.851

3.  Bilirubin is an antioxidant of possible physiological importance.

Authors:  R Stocker; Y Yamamoto; A F McDonagh; A N Glazer; B N Ames
Journal:  Science       Date:  1987-02-27       Impact factor: 47.728

4.  Receptors and growth-promoting effects of insulin and insulinlike growth factors on cells from bovine retinal capillaries and aorta.

Authors:  G L King; A D Goodman; S Buzney; A Moses; C R Kahn
Journal:  J Clin Invest       Date:  1985-03       Impact factor: 14.808

5.  Heme oxygenase-1 induced in muller cells plays a protective role in retinal ischemia-reperfusion injury in rats.

Authors:  Satoko Arai-Gaun; Naomichi Katai; Takanobu Kikuchi; Toru Kurokawa; Kouichi Ohta; Nagahisa Yoshimura
Journal:  Invest Ophthalmol Vis Sci       Date:  2004-11       Impact factor: 4.799

Review 6.  Oxygen radicals and human disease.

Authors:  C E Cross; B Halliwell; E T Borish; W A Pryor; B N Ames; R L Saul; J M McCord; D Harman
Journal:  Ann Intern Med       Date:  1987-10       Impact factor: 25.391

7.  Regulation of vascular permeability in cell culture.

Authors:  G L King; A B Berman; S Bonner-Weir; M P Carson
Journal:  Diabetes       Date:  1987-12       Impact factor: 9.461

Review 8.  Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications.

Authors:  M D Maines
Journal:  FASEB J       Date:  1988-07       Impact factor: 5.191

9.  Requirement for activation of the serine-threonine kinase Akt (protein kinase B) in insulin stimulation of protein synthesis but not of glucose transport.

Authors:  T Kitamura; W Ogawa; H Sakaue; Y Hino; S Kuroda; M Takata; M Matsumoto; T Maeda; H Konishi; U Kikkawa; M Kasuga
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

10.  Heme oxygenase is the major 32-kDa stress protein induced in human skin fibroblasts by UVA radiation, hydrogen peroxide, and sodium arsenite.

Authors:  S M Keyse; R M Tyrrell
Journal:  Proc Natl Acad Sci U S A       Date:  1989-01       Impact factor: 11.205

View more
  28 in total

1.  Oxidative damage is present in the fatal brain edema of diabetic ketoacidosis.

Authors:  William H Hoffman; Sandra L Siedlak; Yang Wang; Rudy J Castellani; Mark A Smith
Journal:  Brain Res       Date:  2010-10-30       Impact factor: 3.252

Review 2.  Vascular effects of exercise: endothelial adaptations beyond active muscle beds.

Authors:  Jaume Padilla; Grant H Simmons; Shawn B Bender; Arturo A Arce-Esquivel; Jeffrey J Whyte; M Harold Laughlin
Journal:  Physiology (Bethesda)       Date:  2011-06

3.  Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice.

Authors:  Christian Rask-Madsen; Qian Li; Bryn Freund; Danielle Feather; Roman Abramov; I-Hsien Wu; Kai Chen; Junko Yamamoto-Hiraoka; Jan Goldenbogen; Konstantinos B Sotiropoulos; Allen Clermont; Pedro Geraldes; Claudia Dall'Osso; Amy J Wagers; Paul L Huang; Mark Rekhter; Rosario Scalia; C Ronald Kahn; George L King
Journal:  Cell Metab       Date:  2010-05-05       Impact factor: 27.287

4.  Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function.

Authors:  Kyoungmin Park; Qian Li; Net Daş Evcimen; Christian Rask-Madsen; Yasutaka Maeda; Ernesto Maddaloni; Hisashi Yokomizo; Takanori Shinjo; Ronald St-Louis; Jialin Fu; Daniel Gordin; Mogher Khamaisi; David Pober; Hillary Keenan; George L King
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-11-21       Impact factor: 8.311

5.  Role of matrix metalloproteinase-2 and -9 in the development of diabetic retinopathy.

Authors:  Ghulam Mohammad; Mohammad Mairaj Siddiquei
Journal:  J Ocul Biol Dis Infor       Date:  2012-07-06

6.  Epigallocatechin gallate induces expression of heme oxygenase-1 in endothelial cells via p38 MAPK and Nrf-2 that suppresses proinflammatory actions of TNF-α.

Authors:  Philomena Pullikotil; Hui Chen; Ranganath Muniyappa; Cynthia C Greenberg; Shutong Yang; Chad E N Reiter; Ji-Won Lee; Jay H Chung; Michael J Quon
Journal:  J Nutr Biochem       Date:  2011-12-01       Impact factor: 6.048

Review 7.  Role of heme oxygenase in inflammation, insulin-signalling, diabetes and obesity.

Authors:  Joseph Fomusi Ndisang
Journal:  Mediators Inflamm       Date:  2010-05-18       Impact factor: 4.711

8.  Resveratrol protects against polychlorinated biphenyl-mediated impairment of glucose homeostasis in adipocytes.

Authors:  Nicki A Baker; Victoria English; Manjula Sunkara; Andrew J Morris; Kevin J Pearson; Lisa A Cassis
Journal:  J Nutr Biochem       Date:  2013-12       Impact factor: 6.048

9.  Serine phosphorylation sites on IRS2 activated by angiotensin II and protein kinase C to induce selective insulin resistance in endothelial cells.

Authors:  Kyoungmin Park; Qian Li; Christian Rask-Madsen; Akira Mima; Koji Mizutani; Jonathon Winnay; Yasutaka Maeda; Katharine D'Aquino; Morris F White; Edward P Feener; George L King
Journal:  Mol Cell Biol       Date:  2013-06-17       Impact factor: 4.272

10.  Bilirubin increases insulin sensitivity in leptin-receptor deficient and diet-induced obese mice through suppression of ER stress and chronic inflammation.

Authors:  Huansheng Dong; Hu Huang; Xinxu Yun; Do-sung Kim; Yinan Yue; Hongju Wu; Alton Sutter; Kenneth D Chavin; Leo E Otterbein; David B Adams; Young-Bum Kim; Hongjun Wang
Journal:  Endocrinology       Date:  2014-01-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.